SURF - Surface Oncology, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
58.28M
Enterprise Value 3
-35.16M
Trailing P/E
N/A
Forward P/E 1
-0.98
PEG Ratio (5 yr expected) 1
N/A
Price/Sales (ttm)
2.36
Price/Book (mrq)
0.84
Enterprise Value/Revenue 3
-1.42
Enterprise Value/EBITDA 6
0.78

Trading Information

Stock Price History

Beta (3Y Monthly) N/A
52-Week Change 3-73.89%
S&P500 52-Week Change 319.31%
52 Week High 39.0800
52 Week Low 31.1500
50-Day Moving Average 31.7546
200-Day Moving Average 32.2089

Share Statistics

Avg Vol (3 month) 390.47k
Avg Vol (10 day) 387.12k
Shares Outstanding 527.88M
Float 10.29M
% Held by Insiders 114.96%
% Held by Institutions 172.41%
Shares Short (Nov 15, 2019) 4178.65k
Short Ratio (Nov 15, 2019) 43.17
Short % of Float (Nov 15, 2019) 41.45%
Short % of Shares Outstanding (Nov 15, 2019) 40.64%
Shares Short (prior month Oct 15, 2019) 4159.97k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Sep 30, 2019

Profitability

Profit Margin -176.50%
Operating Margin (ttm)-188.84%

Management Effectiveness

Return on Assets (ttm)-17.92%
Return on Equity (ttm)-49.79%

Income Statement

Revenue (ttm)24.68M
Revenue Per Share (ttm)0.89
Quarterly Revenue Growth (yoy)-80.10%
Gross Profit (ttm)6.92M
EBITDA -44.93M
Net Income Avi to Common (ttm)-43.57M
Diluted EPS (ttm)-1.5660
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)111.8M
Total Cash Per Share (mrq)4.01
Total Debt (mrq)20.88M
Total Debt/Equity (mrq)30.27
Current Ratio (mrq)7.34
Book Value Per Share (mrq)2.47

Cash Flow Statement

Operating Cash Flow (ttm)-60.74M
Levered Free Cash Flow (ttm)-35.6M